Recruiting Hemophilia Studies in Iowa City
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Terminat...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants wit...
About Hemophilia Clinical Trials in Iowa City
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 2 hemophilia clinical trials recruiting participants in Iowa City, IOWA. These studies are seeking a combined 305 participants. Research is being sponsored by Pfizer, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in Iowa City — FAQ
Are there hemophilia clinical trials in Iowa City?
Yes, there are 2 hemophilia clinical trials currently recruiting in Iowa City, IOWA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated March 2, 2026 from ClinicalTrials.gov